New customers underscore significant interest in ScaleUp Bio’s unique CDMO value proposition to the global food tech industry
ScaleUp Bio, a pioneering, Singapore-based, CDMO provider of submerged microbial precision fermentation facilities, expertise and services announced an initial list of customers, underscoring strong global interest in the company’s unique value proposition:
Collaboration agreement with Australia’s Nourish Ingredients, to support its Asian growth strategy signed letters of Intent with USA’s C16 Biosciences, Malaysia-based Ultimeat, and Singapore’s own Allium Bio to explore the development of sustainable ingredients for the Asian marketplace
Nourish Ingredients, C16 Biosciences, Ultimeat, and Allium Bio – amongst other prospective customers – each leverage submerged microbial and precision fermentation to develop sustainably produced ingredients for novel foods. ScaleUp Bio is playing a vital role in providing these innovators in the food tech space with a bench-to-market pipeline, aiding them in scaling up to pilot-scale commercial production, breaking into Asian markets and beyond. ScaleUp Bio is collaborating with its first customer partner, Australia’s Nourish Ingredients, to bring sustainable fermentation-based speciality fats to an Asian audience. ScaleUp Bio is uniquely positioned via its specialised expertise to deliver assistance, insights, and regulatory advice for companies to succeed in Asia.
